A detailed history of Strs Ohio transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 2,800 shares of AXSM stock, worth $253,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,800
Previous 4,400 36.36%
Holding current value
$253,428
Previous $351,000 35.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$65.72 - $80.5 $105,152 - $128,800
-1,600 Reduced 36.36%
2,800 $225,000
Q1 2024

May 13, 2024

SELL
$69.39 - $97.64 $111,024 - $156,224
-1,600 Reduced 26.67%
4,400 $351,000
Q4 2023

Jan 30, 2024

SELL
$57.42 - $83.61 $200,970 - $292,635
-3,500 Reduced 36.84%
6,000 $477,000
Q3 2023

Oct 26, 2023

BUY
$69.25 - $82.21 $145,425 - $172,641
2,100 Added 28.38%
9,500 $663,000
Q2 2023

Jul 31, 2023

BUY
$58.41 - $90.35 $40,887 - $63,244
700 Added 10.45%
7,400 $531,000
Q1 2023

Aug 02, 2023

SELL
$58.39 - $75.0 $40,873 - $52,500
-700 Reduced 9.46%
6,700 $413,000
Q1 2023

Apr 27, 2023

BUY
$58.39 - $75.0 $169,331 - $217,500
2,900 Added 76.32%
6,700 $413,000
Q4 2022

Jan 26, 2023

BUY
$39.94 - $79.72 $151,772 - $302,936
3,800 New
3,800 $293,000
Q1 2022

Apr 21, 2022

SELL
$23.7 - $41.39 $109,020 - $190,394
-4,600 Closed
0 $0
Q4 2021

Jan 24, 2022

SELL
$30.7 - $43.36 $24,560 - $34,688
-800 Reduced 14.81%
4,600 $173,000
Q3 2021

Oct 22, 2021

BUY
$19.91 - $68.26 $107,514 - $368,604
5,400 New
5,400 $177,000
Q1 2021

Apr 23, 2021

SELL
$55.91 - $81.44 $61,500 - $89,584
-1,100 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$66.31 - $86.52 $510,587 - $666,204
-7,700 Reduced 87.5%
1,100 $89,000
Q2 2020

Jul 23, 2020

BUY
$49.87 - $98.69 $249,350 - $493,450
5,000 Added 131.58%
8,800 $724,000
Q1 2020

Apr 23, 2020

BUY
$41.2 - $101.31 $156,560 - $384,978
3,800 New
3,800 $223,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.88B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.